Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Blin

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
L'Encephale|January 9, 2004
[From neuroleptics toward antipsychotics: psychopharmacology stand point]O Blin
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 4, 1999
A comparative review of new antipsychoticsO Blin
Advances in Neurology|January 1, 1995
Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonist be used in amyotrophic lateral sclerosis?O Blin
L'Encephale|April 11, 2001
Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?O Blin
Clinical Neuropharmacology|April 1, 1993
Pharmacological basis of immunotherapy in autoimmune diseasesB Rouveix, O Blin
Clinical Neuropharmacology|August 2, 2001
Neurobiology and clinical pharmacology of obsessive-compulsive disorderJ Micallef, O Blin
The Journal of Clinical Psychiatry|May 11, 2001
Antipsychotic-associated weight gain and clinical outcome parametersO Blin, J Micallef
Behavioural Brain Research|November 26, 1991
A comparison between the effect of intentional modulations and the action of L-dopa on gait in Parkinson's diseaseA M Ferrandez, O Blin
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1987
[Ischemic cerebral symptoms and psychosocial factors]C Derouesné, O Blin, S Bakchine
Neurology|January 1, 1992
Contrast sensitivity is increased in a case of nonparkinsonian freezing gaitD Mestre, O Blin, G Serratrice
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
L'Encephale|January 9, 2004
[From neuroleptics toward antipsychotics: psychopharmacology stand point]O Blin
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 4, 1999
A comparative review of new antipsychoticsO Blin
Advances in Neurology|January 1, 1995
Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonist be used in amyotrophic lateral sclerosis?O Blin
L'Encephale|April 11, 2001
Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?O Blin
Clinical Neuropharmacology|April 1, 1993
Pharmacological basis of immunotherapy in autoimmune diseasesB Rouveix, O Blin
Clinical Neuropharmacology|August 2, 2001
Neurobiology and clinical pharmacology of obsessive-compulsive disorderJ Micallef, O Blin
The Journal of Clinical Psychiatry|May 11, 2001
Antipsychotic-associated weight gain and clinical outcome parametersO Blin, J Micallef
Behavioural Brain Research|November 26, 1991
A comparison between the effect of intentional modulations and the action of L-dopa on gait in Parkinson's diseaseA M Ferrandez, O Blin
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1987
[Ischemic cerebral symptoms and psychosocial factors]C Derouesné, O Blin, S Bakchine
Neurology|January 1, 1992
Contrast sensitivity is increased in a case of nonparkinsonian freezing gaitD Mestre, O Blin, G Serratrice
Pageof 15